Vincent Esnault

Summary

Country: France

Publications

  1. ncbi Alpha-1-antitrypsin phenotyping in ANCA-associated diseases: one of several arguments for protease/antiprotease imbalance in systemic vasculitis
    V L Esnault
    Service de néphrologie immunologie clinique, CHU Hotel Dieu, Nantes, France
    Exp Clin Immunogenet 14:206-13. 1997
  2. ncbi Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies
    V L Esnault
    Nephrology Clinical Immunology Department, Nantes University Hospital, France
    J Am Soc Nephrol 10:2014-7. 1999
  3. ncbi [Treatment of vasculitis with antineutrophil cytoplasmic autoantibodies (ACPN)]
    V L Esnault
    Service de néphrologie immunologie clinique, Hotel Dieu, 30, bd Jean Monnet, F44093 Nantes
    Presse Med 30:1122-5. 2001
  4. ncbi [Treatment of vasculitis without antineutrophil cytoplasmic autoantibodies]
    V L Esnault
    Service de néphrologie immunologie clinique, Hotel Dieu, 30, bd Jean Monnet, F44093 Nantes
    Presse Med 30:1126-9. 2001
  5. ncbi Radiocontrast media-induced nephrotoxicity in patients with renal failure: rationale for a new double-blind, prospective, randomized trial testing calcium channel antagonists
    Vincent L M Esnault
    , , Nantes, France
    Nephrol Dial Transplant 17:1362-4. 2002
  6. ncbi What is the value of Tc-99m hydroxymethylene diphosphonate scintigraphy for the etiological diagnosis of mild rhabdomyolysis?
    Vincent L M Esnault
    Department of Nephrology Clinical Immunology, Nantes University Hospital, Nantes, France
    Clin Nucl Med 32:519-23. 2007
  7. ncbi [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases]
    Vincent Esnault
    Services de néphrologie immunologie clinique, Hotel Dieu, 44093 Nantes, France
    Nephrol Ther 2:S193-6. 2006
  8. ncbi Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents
    Vincent L M Esnault
    Service de Néphrologie et Immunologie Clinique, CHU de Nantes, 30 Boulevard Jean Monnet, 44093 Nantes, France
    J Am Soc Nephrol 16:474-81. 2005
  9. ncbi Angiotensin-converting-enzyme inhibitors and diuretics for hypertension
    Vincent L M Esnault
    N Engl J Med 349:90-3; author reply 90-3. 2003
  10. ncbi The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study
    Vincent L M Esnault
    Pasteur Hospital, Universite de Nice Sofia Antipolis, Nice, France
    Clin Ther 30:482-98. 2008

Collaborators

Detail Information

Publications11

  1. ncbi Alpha-1-antitrypsin phenotyping in ANCA-associated diseases: one of several arguments for protease/antiprotease imbalance in systemic vasculitis
    V L Esnault
    Service de néphrologie immunologie clinique, CHU Hotel Dieu, Nantes, France
    Exp Clin Immunogenet 14:206-13. 1997
    ..This imbalance may at least contribute to disease spreading or aggravation...
  2. ncbi Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies
    V L Esnault
    Nephrology Clinical Immunology Department, Nantes University Hospital, France
    J Am Soc Nephrol 10:2014-7. 1999
    ....
  3. ncbi [Treatment of vasculitis with antineutrophil cytoplasmic autoantibodies (ACPN)]
    V L Esnault
    Service de néphrologie immunologie clinique, Hotel Dieu, 30, bd Jean Monnet, F44093 Nantes
    Presse Med 30:1122-5. 2001
    ..FOLLOW-UP: Close monitoring of ANCA levels is important in these patients. Several protocols are currently under evaluation with the aim of limiting immunosuppression toxicity...
  4. ncbi [Treatment of vasculitis without antineutrophil cytoplasmic autoantibodies]
    V L Esnault
    Service de néphrologie immunologie clinique, Hotel Dieu, 30, bd Jean Monnet, F44093 Nantes
    Presse Med 30:1126-9. 2001
    ..A large range of treatments have been proposed, but there is little solid evidence concerning efficacy...
  5. ncbi Radiocontrast media-induced nephrotoxicity in patients with renal failure: rationale for a new double-blind, prospective, randomized trial testing calcium channel antagonists
    Vincent L M Esnault
    , , Nantes, France
    Nephrol Dial Transplant 17:1362-4. 2002
  6. ncbi What is the value of Tc-99m hydroxymethylene diphosphonate scintigraphy for the etiological diagnosis of mild rhabdomyolysis?
    Vincent L M Esnault
    Department of Nephrology Clinical Immunology, Nantes University Hospital, Nantes, France
    Clin Nucl Med 32:519-23. 2007
    ..However, the performance of bone scintigraphy in mild rhabdomyolysis is unknown. The etiological diagnosis of rhabdomyolysis can be difficult, particularly in alcohol abusers who deny a recent alcoholic binge...
  7. ncbi [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases]
    Vincent Esnault
    Services de néphrologie immunologie clinique, Hotel Dieu, 44093 Nantes, France
    Nephrol Ther 2:S193-6. 2006
    ..Thus, the reduction of proteinuria or the prevention of its appearance with renin angiotensin system blockers is the main therapeutic strategy to prevent the evolution of nephropathy in diabetic patients...
  8. ncbi Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents
    Vincent L M Esnault
    Service de Néphrologie et Immunologie Clinique, CHU de Nantes, 30 Boulevard Jean Monnet, 44093 Nantes, France
    J Am Soc Nephrol 16:474-81. 2005
    ....
  9. ncbi Angiotensin-converting-enzyme inhibitors and diuretics for hypertension
    Vincent L M Esnault
    N Engl J Med 349:90-3; author reply 90-3. 2003
  10. ncbi The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study
    Vincent L M Esnault
    Pasteur Hospital, Universite de Nice Sofia Antipolis, Nice, France
    Clin Ther 30:482-98. 2008
    ....
  11. ncbi High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial
    Felix Cantarovich
    Department of Transplantation and Intensive Care, Necker Hospital, Paris, France
    Am J Kidney Dis 44:402-9. 2004
    ..The effect of furosemide on the survival and renal recovery of patients presenting with acute renal failure (ARF) is still debated...